Peter Attia· MD
prior to that David it was predicted that Hep C was going to be accounting for something to the tune of 70% of liver transplants
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
prior to that David it was predicted that Hep C was going to be accounting for something to the tune of 70% of liver transplants
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
chris when you and i were in medical school and residency for that matter it seemed abundantly clear that hepatitis c was going to overwhelm the liver transplant infrastructure within the united states today there's good news and there's bad news the good news is that hepatitis c is not going to overwhelm the liver transplant infrastructure of the united states the bad news is that something else is going to do that and that's nafldy and nash
the good news is that hepatitis c is not going to overwhelm the liver transplant infrastructure of the united states